A second mediastinoscopy: how to decide and how to do it?

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 4, 2008, Pages 703-706

  Van Schil, Paul E ^a   De Waele, Michèle ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Induction therapy; Lung cancer; Mediastinoscopy; Remediastinoscopy; Restaging; Staging

Indexed keywords

ACCURACY; AORTA ARCH; BRACHIOCEPHALIC TRUNK; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; HUMAN; IMAGING SYSTEM; LUNG CANCER; MEDIASTINOSCOPY; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SURGICAL TECHNIQUE; THORACOTOMY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MEDIASTINOSCOPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REOPERATION; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 40649093014     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.01.016     Document Type: Review

References (20)

1. Betticher D.C., Hsu Schmitz S.F., Totsch M., Hansen E., Joss C., von Briel C., Schmid R.A., Pless M., Habicht J., Roth A.D., Spiliopoulos A., Stahel R., Weder W., Stupp R., Egli F., Furrer M., Honegger H., Wernli M., Cerny T., and Ris H.B. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
2. Kim E.S., and Bosquée L. The importance of accurate lymph node staging in early and locally advanced non-small cell lung cancer: an update on available techniques. J Thorac Oncol 2 Suppl. 2 (2007) S59-S67
3. De Waele M., Hendriks J., Lauwers P., Ortmanns P., Vanroelen W., Morel A.M., Germonpré P., and Van Schil P. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg 29 (2006) 240-243
4. Pauwels M., Van Schil P., De Backer W., Van den Brande F., and Eyskens E. Repeat mediastinoscopy in the staging of lung cancer. Eur J Cardiothorac Surg 14 (1998) 271-273
5. Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cirera-Nogueras L., and Gonzalez-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 391-395
6. Stamatis G., Fechner S., Hillejan L., Hinterthaner M., and Krbek T. Repeat mediastinoscopy as a restaging procedure. Pneumologie 59 (2005) 862-866
7. Van Schil P., and Stamatis G. Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement or surgical technique?. J Clin Oncol 24 (2006) 5338
8. Akhurst T., Downey R.J., Ginsberg M.S., Gonen M., Bains M., Korst R., Ginsberg R.J., Rusch V.W., and Larson S.M. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73 (2002) 259-266
9. Port J.L., Kent M.S., Korst R.J., Keresztes R., Levin M.A., and Altorki N.K. Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer. Ann Thorac Surg 77 (2004) 254-259
10. De Leyn P., Stoobants S., De Wever W., Lerut T., Coosemans W., Decker G., Nafteux P., Van Raemdonck D., Mortelmans L., Nackaerts K., and Vansteenkiste J. Prospective comparative study of integrated PET-CT compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 24 (2006) 333-339
11. Cerfolio R.J., Bryant A.S., and Ojha B. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 131 (2006) 1229-1235
12. Pitz C.C., Maas K.W., van Swieten H.A., de la Riviere A.B., Hofman P., and Schramel F.M. Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer. Ann Thorac Surg 74 (2002) 164-169
13. Rami-Porta R., Mateu-Navarro M., Serra-Mitjans M., and Hernandez-Rodriguez H. Remediastinoscopy: comments and updated results. Lung Cancer 42 (2003) 363-364
14. De Waele M., Serra-Mitjans M., Hendriks J., Lauwers P., Belda-Sanchis J., Van Schil P., and Rami-Porta R. Accuracy and survival of repeat mediastinoscopy (reMS) after induction therapy for non-small cell lung cancer (NSCLC) in a combined series of 104 patients. Interact Cardiovasc Thorac Surg 6 suppl. 3 (2007) S252 [abstract 108]
15. Jaklitsch M.T., Gu L., Harpole D.H., D'Amico T.A., McKenna R.J., Krasna M.J., Kohman L.J., Swanson S.J., Decamp M.M., and Sugarbaker D.J. Prospective phase II trial of pre-resection thoracoscopic (VATS) restaging following neoadjuvant therapy for IIIA (N2) non-small cell lung cancer (NSCLC) results of CALGB 39803. J Clin Oncol 23 16S (2005) 636s [abstract 7065]
16. Annema J.T., Veselic M., Versteegh M.I., Willems L.N., and Rabe K.F. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer 42 (2003) 311-318
17. Krasnik M., Ernst A., Eberhardt R., Yasufuku K., and Herth F. EBUS-TNA for mediastinal restaging. Eur Resp J 28 suppl. 50 (2006) 601s-602s [abstract 3541]
18. Kunst P.W., Lee P., Paul M.A., Senan S., and Smit E.F. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer. J Thorac Oncol 2 (2007) 912-915
19. Van Schil P., De Waele M., Hendriks J., and Lauwers P. Remediastinoscopy. J Thor Oncol 2 (2007) 365-366
20. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., and Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 (2007) 1-8